KOKursad Ozsahin

Kursad Ozsahin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kursad Ozsahin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Eda Ertorer

    Department of Endocrinology and Metabolism Diseases, Faculty of Medicine, Baskent University, Dadaloglu Mah Serinevler, 01250 Adana, Turkey

    1 shared publication
  • Emine Duygu Ersozlu Bozkirli

    Department of Internal Medicine, School of Medicine, Başkent University, 01250 Adana, Turkey

    1 shared publication
  • Emre Bozkirli

    Department of Endocrinology and Metabolism Diseases, Faculty of Medicine, Baskent University, Dadaloglu Mah Serinevler, 01250 Adana, Turkey

    1 shared publication
  • Filiz Eksi Haydardedeoglu

    Baskent University Faculty of Medicine, Adana Dr. Turgut Noyan Teaching and Research Center

    1 shared publication
  • Gulay Simsek Bagir

    Department of Endocrinology and Metabolism, Başkent University Faculty of Medicine, Adana, Türkiye

    1 shared publication
  • Gulhan Cavlak

    Department of Endocrinology and Metabolism Diseases, Faculty of Medicine, Baskent University, Dadaloglu Mah Serinevler, 01250 Adana, Turkey

    1 shared publication

Latest Publications

  • Open Access

    Impact of fasting during Ramadan in patients with type 2 diabetes mellitus

    by Filiz Ekşi̇ Haydardedeoğlu, Gülay Şi̇mŞek Bağir, Akatlı Kürşat ÖZŞAHİN

    Purpose: Fasting during Ramadan is a religious obligation for Muslims. Extended fasting can create undesirable acute complications of diabetes such as hypoglycemia or hyperglycemia. In this study, we aimed to evaluate the impact of fasting on glucose regulation in diabetic patients who fast during Ramadan.Materials and Methods: Patients were informed about the possible side effects of fasting for them and those who stated that they will be fasting during Ramadan were called one month after Ramadan. In this retrospective cohort study by telephone interview, the number of fasting days, daily measurements of glucose, the number of acute complications if existed and whether the patients have changed their treatments were asked.Results: Forty six patients were included in this study. Mean age was 54.3±9.5 yr. The average fasting day was 25.24±2.4. They were categorized according to the risk stratifications. The number of hypoglycemic events was not higher than detected six months prior to the Ramadan. Most of the patients had hyperglycemia rather than hypoglycemia. All of the patients who had hypo-or hyperglycemia did not interrupt their fasting and did not change their medications. Conclusion: Patients who fasted during Ramadan have a tendency both hypoglycemia and hyperglycemia. To improve glycemic regulation and keep these patients in a safe and acceptable glucose range, Pre-Ramadan education is necessary.


  • Open Access

    Are Plasma Thyroid-Stimulating Hormone Levels Associated with Degree of Obesity and Metabolic Syndrome in Euthyroid Obese Patients? A Turkish Cohort Study

    by Okan Bakiner, Emre Bozkirli, Gulhan Cavlak, Kursad Ozsahin, Eda Ertorer

    We aimed to observe the association between degree of obesity and metabolic syndrome and plasma thyrotropin levels in obese, euthyroid Turkish patients. 947 obese and overweight patients who admitted to our outpatient clinic were assessed retrospectively. 150 healthy euthyroid cases were also recruited as the control group. Cases with metabolic syndrome were determined. Patients were divided into various subgroups as overweight, obese, morbid obese, men, and women. No statistical significance was determined when all the patients’ and subgroups’ plasma thyrotropin levels were compared to normal weight control group. No association was shown between the presence of metabolic syndrome and plasma thyrotropin levels for both all patients and subgroups. Also there was not any association between each component of metabolic syndrome and plasma thyrotropin levels. In conclusion, we did not found any significant association between plasma thyrotropin levels and obesity and metabolic syndrome in our euthyroid subjects.


  • Open Access

    Correction of Hypothyroidism Seems to Have No Effect on Body Fat

    by Okan Bakiner, Emine Duygu Ersozlu Bozkirli, Kursat Ozsahin

    Aim. We aimed to observe the effects of L-thyroxine replacement therapy on body fat content determined with various anthropometric methods and a bioelectrical impedance analysis method in patients with hypothyroidism.Methods. Forty-two women with naive autoimmune hypothyroidism were included. Also, 40 healthy participants were enrolled as a control group. Weight, body mass index, waist circumference, and subscapulary, suprailiac, femur, biceps, and triceps skin fold thicknesses were measured. Body fat percentages were calculated and body fat measurements were performed. Euthyroidism was maintained with L-thyroxine. At the 6th and 18th month, of therapy, measurements were reperformed.Results. Mean TSH levels were mIU/L in hypothyroid group and mIU/L in control subjects at admission. In hypothyroid patients, calculated body fat percentages were greater than those of the control subjects during follow-up. Body fat percentage of each hypothyroid case decreased at 6- and 18-month controls, but the decrements were statistically insignificant. Although skin fold thicknesses measured from all sites were observed to decline, only those obtained from femur and biceps showed a significant decrease ( and , resp.).Discussion. Correction of hypothyroidism did not cause any improvement in body weight and body fat percentage. The decrease in skin fold thicknesses might probably result from the reduction in subcutaneous mucopolysaccharide deposits.